Seracare Bioservices

Gaithersburg, MD 20877

SBIR Award Summary

Total Number of Awards 14
Total Value of Awards $692K
First Award Date 07/01/94
Most Recent Award Date 03/01/04

Key Personnel

Last Name Name Awards Contact
Gonzalez Lucia I. Gonzalez 3
Manak Mark M Manak 3
Ji Jiuping J Ji 4
Lopaczynski Wlodek Lopaczynski 1
Nakhai Bita Nakhai 2
Allaway Graham P Allaway 1

14 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/04 - 02/28/05

DESCRIPTION (provided by investigator): This application describes the feasibility study of using Boston Biomedica, Inc.'s proprietary Pressure Cycling Technology (PCT), its instrument (BarocylcerTM) and its novel sample preparation tube (PULSE) as a new method to collect, transport, store, grow (if necessary), and process microorganisms that m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/04/03 - 09/30/04

DESCRIPTION (provided by applicant): Some epidemiological studies are so large that it would be too expensive to isolate peripheral blood mononuclear cells (PBMCs) from every donor enrolled in them. Therefore, research studies, such as the Retrovirus Epidemiology Donors Study (REDS) have collected and aliquoted whole blood, added 10 percent v/v ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/02 - 03/31/03

DESCRIPTION (provided by applicant): Prion diseases are 100 percent fatal, there is no treatment available, and cannot be diagnosed prior to the occurrence of symptoms. There is a public health need and an enormous market for a screening test that can help protect the blood supply, screen live animals, and ensure food safety. We propose to devel...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/00 - 07/31/02

A nucleic acid based solid phase microplate capture assay is being developed for the differentiation of the major HIV-1 subtypes of groups M and O. Sample processing conditions is optimized to ensure the assay's sensitivity and reproducibility. Ah internal control vector containing a synthetic fragment flanked by sequences corresponding to the H...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/99 - 07/31/00

A nucleic acid based solid phase microplate capture assay is being developed for the differentiation of the major HIV-1 subtypes of groups M and O. Sample processing conditions is optimized to ensure the assay's sensitivity and reproducibility. Ah internal control vector containing a synthetic fragment flanked by sequences corresponding to the H...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 01/31/00

A specific and reliable plate format for testing large numbers of clinical samples for the genotypes of TTV, a newly described human transfusion hepatitis virus, will be developed. The conditions for sample processing will be optimized to ensure the detection of the virus and the sensitivity and reproducibility using multiple internal and extern...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 01/31/00

Tick-borne diseases represent a significant source of mortality and morbidity in the U.S. Although Lyme Disease is the most prevalent vector- borne disease, two additional diseases, Babesiosis and Ehrlichiosis are transmitted by the same tick vector and share the same host reservoir. These diseases are often misdiagnosed or undiagnosed and bette...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/99 - 12/31/99

BBI-Biotech Research Laboratories and the University of North Carolina are collaborating in a novel approach to identify natural product derivatives that block HIV infection, by focusing on specific plant families with a history of application in traditional medicine. This project proposal will characterize the six most potent drug candidates di...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/98 - 09/30/99

Despite the use of highly sensitive serologic tests for screening blood donations for antibodies to HIV-1, HTLV-I/II, HCV and HBV in US blood centers, the delay between the onset of infection and the antibody response creates a "window" period during which the blood may be infectious but seronega...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/97 - 09/14/98

DESCRIPTION: (Adapted From Applicant's Abstract) This is a Phase I study to develop a molecular assay for the genetic differentiation of the major HIV-1 subtypes in plasma and PBMCs. The assay involves a RT-PCR based capture hybridization format compatible with the microplate ELISA technique. Biotin-label...

Load More